The process of red biotechnology makes use of various organisms for the betterment of healthcare and to build immunity against diseases. This modern branch of biotechnology has been used for the medical field. This has been of great use not only in pharmaceutical as well as the medical industry and has helped to enhance the lifestyle quality along with reducing the suffering of humans. Furthermore, red biotechnology has been utilized in various fields such as gene therapy, diagnostics, clinical trials, and research.
Download PDF Sample Report: https://www.alliedmarketresearch.com/request-sample/8729
Companies covered
Pfizer, Inc., Biogen Inc., Amgen Inc., AstraZeneca Plc., Gilead Sciences, Inc., CELGENE CORPORATION, F. Hoffmann-La Roche, Ltd., Merck KGaA, Regeneron Pharmaceuticals, Inc., and Takeda Pharmaceutical Company Limited
COVID-19 scenario analysis:
- Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges.
- Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs, such as hydroxychloroquine, have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs as many developed countries are short of these drugs.
- The pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19.
- Attributed to such factors, COVID 19 is expected to have a significant impact on the red biotechnology market.
New product launches to boost the market
On June 13th, 2019, Allergan PLC and Amgen got approval from the US FDA for their products KANJINTI and Herceptin. On December, 8th, 2018, China’s National Medical Products Administration approved Harvoni from Gilead Sciences, Inc.
Surge in usage in hospital applications
The biopharmaceutical industry, CMOs & CROs, and research institutes are the major consumers of the red biotechnology market. Amongst them, the biopharmaceutical industry and CMOS & CROs are the biggest end users in the market. This is due to the significant rise in clinical trials and the number of acceptance for expansion strategies by key players and manufacturers in developing countries for cost reduction and upgrading their position in the red biotechnology market.
Key segments covered:
Application
- Biopharmaceutical Production
- Gene Therapy
- Pharmacogenomics
- Genetic Testing
Product Type
- Gene Recombinant Drugs
- Human Vaccines
- Blood Products
- Diagnostics Reagents
- Personalized Medicines
- Others
Key benefits of the report:
- This study presents the analytical depiction of the red biotechnology market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the red biotechnology market share.
- The current market is quantitatively analyzed from 2020 to 2027 to highlight the red biotechnology market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/8729
Similar Reports:
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.